×
Stereotaxis Total Long Term Liabilities 2010-2025 | STXS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stereotaxis total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
View More
Stereotaxis Total Long Term Liabilities 2010-2025 | STXS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Stereotaxis total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$180.6B
Intuitive Surgical (ISRG)
$177.8B
Edwards Lifesciences (EW)
$46.9B
IDEXX Laboratories (IDXX)
$45.5B
Alcon (ALC)
$45.3B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$33.9B
Mettler-Toledo (MTD)
$26.3B
STERIS (STE)
$22.7B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.5B
Hologic (HOLX)
$14.8B
Sysmex ADR (SSMXY)
$10.7B
Penumbra (PEN)
$9B
Masimo (MASI)
$8.9B
Globus Medical (GMED)
$7.4B
Glaukos (GKOS)
$5.4B
Teleflex (TFX)
$5.2B
Integer Holdings (ITGR)
$3.8B
TransMedics (TMDX)
$3.7B
PROCEPT BioRobotics (PRCT)
$3.1B
LivaNova (LIVN)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
Elekta AB (EKTAY)
$2B
Veracyte (VCYT)
$2B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Tandem Diabetes Care (TNDM)
$1.1B